Health Sciences Group Provides Update on Kalahari Acquisition
01 12월 2006 - 10:30PM
Business Wire
Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative
health and wellness products, announces continued progress towards
the execution of its previously announced acquisition of Kalahari
Limited. Pursuant to the terms of the amended letter of intent, the
anticipated closing date was extended to December 31, 2006.
Kalahari� Limited is a specialty tea and food company whose
products are sold in over 5,000 stores nationwide. �Due diligence
is proceeding routinely, with most milestones being achieved as
expected," said Fred E. Tannous, Co-chairman and chief financial
officer of Health Sciences Group, Inc. �We expect to complete
outstanding prerequisite items within the next 30 days leading to a
signed definitive agreement by year-end.� About Kalahari Limited
Kalahari (www.KalahariLtd.com) offers healthy products that are
Fuel for Life�s Safari. Kalahari teas, bottled iced teas and Fruit
Trekker�, 100% fruit energy bars, are sold in over 5,000
supermarkets, natural food stores and specialty retailers
nationwide. About Health Sciences Group, Inc. Health Sciences Group
is dedicated to developing and acquiring unique and innovative
products that support and enhance a "healthstyle" with a focus on
nutrition, wellness and functional well-being. For more
information, visit www.HealthSciencesGroup.com. This release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Act of 1934 that are based upon current expectations or beliefs, as
well as a number of assumptions about future events. Although the
Company believes that the expectations reflected in the
forward-looking statements and the assumptions upon which they are
based are reasonable, it can give no assurance that such
expectations and assumptions will prove to have been correct. The
reader is cautioned not to put undue reliance on these
forward-looking statements, as these statements are subject to
numerous factors and uncertainties, including without limitation,
the independent authority of the special committee to act on the
matters discussed, the successful negotiation of the potential
acquisition and disposal of transactions described above,
successful implementation of the company's business strategy and
competition, any of which may cause actual results to differ
materially from those described in the statements. In addition,
other factors that could cause actual results to differ materially
are discussed in the Company's most recent Form 10-QSB and Form
10-KSB filings with the Securities and Exchange Commission. Health
Sciences Group, Inc. (OTCBB:HESG), provider of innovative health
and wellness products, announces continued progress towards the
execution of its previously announced acquisition of Kalahari
Limited. Pursuant to the terms of the amended letter of intent, the
anticipated closing date was extended to December 31, 2006.
Kalahari(R) Limited is a specialty tea and food company whose
products are sold in over 5,000 stores nationwide. "Due diligence
is proceeding routinely, with most milestones being achieved as
expected," said Fred E. Tannous, Co-chairman and chief financial
officer of Health Sciences Group, Inc. "We expect to complete
outstanding prerequisite items within the next 30 days leading to a
signed definitive agreement by year-end." About Kalahari Limited
Kalahari (www.KalahariLtd.com) offers healthy products that are
Fuel for Life's Safari. Kalahari teas, bottled iced teas and Fruit
Trekker(R), 100% fruit energy bars, are sold in over 5,000
supermarkets, natural food stores and specialty retailers
nationwide. About Health Sciences Group, Inc. Health Sciences Group
is dedicated to developing and acquiring unique and innovative
products that support and enhance a "healthstyle" with a focus on
nutrition, wellness and functional well-being. For more
information, visit www.HealthSciencesGroup.com. This release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Act of 1934 that are based upon current expectations or beliefs, as
well as a number of assumptions about future events. Although the
Company believes that the expectations reflected in the
forward-looking statements and the assumptions upon which they are
based are reasonable, it can give no assurance that such
expectations and assumptions will prove to have been correct. The
reader is cautioned not to put undue reliance on these
forward-looking statements, as these statements are subject to
numerous factors and uncertainties, including without limitation,
the independent authority of the special committee to act on the
matters discussed, the successful negotiation of the potential
acquisition and disposal of transactions described above,
successful implementation of the company's business strategy and
competition, any of which may cause actual results to differ
materially from those described in the statements. In addition,
other factors that could cause actual results to differ materially
are discussed in the Company's most recent Form 10-QSB and Form
10-KSB filings with the Securities and Exchange Commission.
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025